475
Views
4
CrossRef citations to date
0
Altmetric
Review

Step-up and step-down approaches in the treatment of asthma

ORCID Icon, , ORCID Icon, ORCID Icon &
Pages 1159-1168 | Received 03 Mar 2021, Accepted 24 May 2021, Published online: 07 Jun 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Mario Cazzola, Luigino Calzetta, Barbara Rinaldi, Vito De Novellis, Paola Rogliani & Maria Gabriella Matera. (2022) Clinical characteristics, treatment patterns and adherence in patients with asthma on multiple inhaler triple therapy: a review of findings. Expert Review of Respiratory Medicine 16:11-12, pages 1205-1212.
Read now
Mario Cazzola, Paola Rogliani, Silvio Naviglio, Luigino Calzetta & Maria Gabriella Matera. (2022) An update on the currently available and emerging synthetic pharmacotherapy for uncontrolled asthma. Expert Opinion on Pharmacotherapy 23:10, pages 1205-1216.
Read now

Articles from other publishers (2)

Mario Cazzola, Fulvio Braido, Luigino Calzetta, Maria Gabriella Matera, Alessio Piraino, Paola Rogliani & Nicola Scichilone. (2022) The 5T approach in asthma: Triple Therapy Targeting Treatable Traits. Respiratory Medicine 200, pages 106915.
Crossref
Mario Cazzola & Maria Gabriella Matera. (2022) Molecular aspects of asthma. Molecular Aspects of Medicine 85, pages 101087.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.